Skip to Content
Merck

MAB10207

Anti-Fusion Glycoprotein of Human parainfluenzavirus Type 3 Antibody, clone 9-4-3

ascites fluid, clone 9-4-3, Chemicon®

Synonym(s):

PI3

Sign In to View Organizational & Contract Pricing.

Select a Size

All Photos(1)

About This Item

UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702

Product Name

Anti-Fusion Glycoprotein of Human parainfluenzavirus Type 3 Antibody, clone 9-4-3, ascites fluid, clone 9-4-3, Chemicon®

biological source

mouse

antibody form

ascites fluid

antibody product type

primary antibodies

clone

9-4-3, monoclonal

species reactivity

human

manufacturer/tradename

Chemicon®

technique(s)

immunofluorescence: suitable

isotype

IgG1

UniProt accession no.

P06828

shipped in

wet ice

Quality Level

300

General description

Human parainfluenza virus type 3 (PI3 virus) causes mild to severe respiratory tract infection in infants. PI3 virus is an enveloped RNA virus and possesses two glycoproteins, hemagglutinin-neuraminidase (HN) and fusion (F), at its external surface. These two glycoproteins are known to be responsible for initiation and progress of the infection process

Immunogen

Fusion (F) glycoprotein of human parainfluenzavirus type 3

Legal Information

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

Not finding the right product?  

Try our Product Selector Tool.

Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

M A Horga et al.
Journal of virology, 74(24), 11792-11799 (2000-11-23)
Viral interference is characterized by the resistance of infected cells to infection by a challenge virus. Mechanisms of viral interference have not been characterized for human parainfluenza virus type 3 (HPF3), and the possible role of the neuraminidase (receptor-destroying) enzyme
Antiviral effects of glycosylation and glucose trimming inhibitors on human parainfluenza virus type 3
Tanaka, Yoshikazu, et al
Antiviral research, 72, 1-9 (2006)
Ying Liu et al.
Virus genes, 56(1), 37-48 (2019-11-27)
Human parainfluenza virus type 3 (HPIV3) causes the majority of childhood viral pneumonia around the world. Fusing the viral and target cell membranes is crucial for its entry into target cells, and the fusion process requires the concerted actions of
Laura M Palermo et al.
Journal of virology, 83(13), 6900-6908 (2009-04-24)
Three discrete activities of the paramyxovirus hemagglutinin-neuraminidase (HN) protein, receptor binding, receptor cleaving (neuraminidase), and triggering of the fusion protein, each affect the promotion of viral fusion and entry. For human parainfluenza virus type 3 (HPIV3), the effects of specific
Wenyan Xie et al.
PloS one, 10(8), e0136474-e0136474 (2015-08-26)
Human parainfluenza virus type 3 (HPIV3) can cause severe respiratory tract diseases in infants and young children, but no licensed vaccines or antiviral agents are currently available for treatment. Fusing the viral and target cell membranes is a prerequisite for

Global Trade Item Number

SKUGTIN
MAB1020704053252666568

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service